MedTrace Logo

Establishment of a Personalized Pharmaceutical Plan in Renal or Hepatic Transplant Patients

NCT04295928 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1716

Last updated 2022-11-03

No results posted yet for this study

Summary

The main objective of the study is to evaluate the impact of the Personalized Pharmaceutical Plan on the therapeutic adherence to immunosuppressive treatments one year after liver or kidney transplantation.

Conditions

  • Personalized Pharmaceutical Plan After Transpantation

Interventions

BEHAVIORAL

PPP

Personalized Pharmaceutical Plan on therapeutic adherence to immunosuppressive treatments after the transplantation

Sponsors & Collaborators

  • Unité d'Epidémiologie des Données cliniques en Centre-Val de Loire (EpiDcliC)

    collaborator UNKNOWN

  • Unité d'Evaluation Médico-Economique (UEME)

    collaborator UNKNOWN

  • University Hospital, Tours

    lead OTHER

Principal Investigators

  • Xavier POURRAT, PhD · University Hospital of TOURS

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-12
Primary Completion
2022-09-11
Completion
2025-09-11

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04295928 on ClinicalTrials.gov